NASDAQ
Celldex Therapeutics, Inc. (CLDX) has a fcf yield of -11.83% as of Friday, June 12, 2026. This represents a 94.76% decrease compared to its 12-month average of -6.07%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.